I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 14 studies | 25% ± 8% | |
| microglial cell | 8 studies | 25% ± 7% | |
| GABAergic neuron | 7 studies | 36% ± 20% | |
| oligodendrocyte | 7 studies | 29% ± 6% | |
| glutamatergic neuron | 6 studies | 46% ± 24% | |
| fibroblast | 6 studies | 29% ± 11% | |
| astrocyte | 6 studies | 30% ± 9% | |
| macrophage | 5 studies | 31% ± 9% | |
| interneuron | 5 studies | 37% ± 23% | |
| cardiac muscle cell | 4 studies | 18% ± 3% | |
| dendritic cell | 4 studies | 17% ± 2% | |
| oligodendrocyte precursor cell | 4 studies | 29% ± 8% | |
| T cell | 4 studies | 19% ± 4% | |
| endothelial cell of lymphatic vessel | 4 studies | 27% ± 6% | |
| pericyte | 4 studies | 27% ± 8% | |
| smooth muscle cell | 4 studies | 23% ± 2% | |
| type I pneumocyte | 4 studies | 21% ± 5% | |
| myeloid cell | 3 studies | 20% ± 1% | |
| epithelial cell | 3 studies | 37% ± 16% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 2% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 22% ± 4% | |
| monocyte | 3 studies | 24% ± 5% | |
| natural killer cell | 3 studies | 21% ± 4% | |
| lymphocyte | 3 studies | 32% ± 10% |
